Journal article
MicroRNA-21 overexpression contributes to vestibular schwannoma cell proliferation and survival
Otology & neurotology, Vol.31(9), pp.1455-1462
12/2010
DOI: 10.1097/MAO.0b013e3181f20655
PMCID: PMC2978772
PMID: 20856158
Abstract
Elevated levels of hsa-microRNA-21 (miR-21) in vestibular schwannomas (VSs) may contribute to tumor growth by downregulating the tumor suppressor phosphatase and tensin homolog (PTEN) and consequent hyperactivation of protein kinase B (AKT), a key signaling protein in the cellular pathways that lead to tumor growth.
Vestibular schwannomas are benign tumors that arise from the vestibular nerve. Left untreated, VSs can result in hearing loss, tinnitus, vestibular dysfunction, trigeminal nerve dysfunction, and can even become life threatening. Despite efforts to characterize the VS transcriptome, the molecular pathways that lead to tumorigenesis are not completely understood. MicroRNAs are small RNA molecules that regulate gene expression posttranscriptionally by blocking the production of specific target proteins.
We examined miR-21 expression in VSs. To determine the functional significance of miR-21 expression in VS cells, we transfected primary human VS cultures with anti-miR-21 or control, scrambled oligonucleotides.
We found consistent overexpression of miR-21 when compared with normal vestibular nerve tissue. Furthermore, elevated levels of miR-21 correlated with decreased levels of PTEN, a known molecular target of miR-21. Anti-miR-21 decreased VS cell proliferation in response to platelet-derived growth factor stimulation and increased apoptosis, suggesting that increased miR-21 levels contributes to VS growth.
Because PTEN regulates signaling through the growth-promoting phosphoinositide 3-kinase/AKT pathway, our findings suggest that miR-21 may be a suitable molecular target for therapies aimed specifically at reducing VS growth.
Details
- Title: Subtitle
- MicroRNA-21 overexpression contributes to vestibular schwannoma cell proliferation and survival
- Creators
- Joseph A Cioffi - Legacy Clinical Research and Technology Center, Portland, Oregon 97232, USA. joeciof@aol.comWei Ying YueSabrina Mendolia-LoffredoKameron R HansenP Ashley WackymMarlan R Hansen
- Resource Type
- Journal article
- Publication Details
- Otology & neurotology, Vol.31(9), pp.1455-1462
- DOI
- 10.1097/MAO.0b013e3181f20655
- PMID
- 20856158
- PMCID
- PMC2978772
- NLM abbreviation
- Otol Neurotol
- ISSN
- 1531-7129
- eISSN
- 1537-4505
- Publisher
- United States
- Grant note
- R01 DC002971-14 / NIDCD NIH HHS R01 DC009801-03 / NIDCD NIH HHS R01 DC009801 / NIDCD NIH HHS K08DC006211 / NIDCD NIH HHS K08 DC006211 / NIDCD NIH HHS R01 DC002971 / NIDCD NIH HHS K08 DC006211-05 / NIDCD NIH HHS R01DC02971 / NIDCD NIH HHS
- Language
- English
- Date published
- 12/2010
- Academic Unit
- Molecular Physiology and Biophysics; Chemical and Biochemical Engineering; Neurosurgery; Otolaryngology
- Record Identifier
- 9984007172402771
Metrics
32 Record Views